Hepatic Steatosis Index Is Associated with Type I Diabetes Complications

被引:17
|
作者
Tripolino, Cesare [1 ]
Irace, Concetta [2 ]
Cutruzzola, Antonio [2 ]
Parise, Martina [1 ]
Barone, Milena [1 ]
Scicchitano, Caterina [1 ]
Cortese, Claudio [3 ]
Gnasso, Agostino [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Clin & Expt Med, Metab Dis Unit, Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
[3] Tor Vergata Univ, Dept Expt Med & Surg, Rome, Italy
来源
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2019年 / 12卷
关键词
fatty liver; type; 1; diabetes; diabetes complications; FATTY LIVER-DISEASE; ADULT PATIENTS; PREVALENCE;
D O I
10.2147/DMSO.S221969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magnetic resonance. Aim: The aim of the present study was to evaluate the possible association between HSI and complications in T1DM. Methods: Medical records of patients with T1DM were evaluated. Macro- and microvascular complications were evaluated by a combination of instrumental (ECG, carotid artery echo-Doppler, fundus examination, vibration threshold at biothesiometry) and laboratory examination. HSI was calculated based on gender, body mass index and transaminases level. Results: Of the 124 patients evaluated, 71 were free of complications and 53 had at least one complication. The prevalence of diabetes complications was: 27% for retinopathy, 15% for carotid atherosclerosis, 16% for neuropathy. HSI was directly correlated with age, disease duration, triglycerides, total daily insulin and inversely with HDL and eGFR. In logistic regression analysis, HSI was independently associated with diabetic complications. Conclusion: These findings show that HSI is independently associated with the presence of complications in subjects with T1DM. This can be of clinical utility, allowing a better diagnostic classification of the patient and possibly guiding the therapeutic choice.
引用
收藏
页码:2405 / 2410
页数:6
相关论文
共 50 条
  • [1] HEPATIC STEATOSIS AS DIABETES TYPE 2 PREDICTOR
    Loureiro, Carolina
    Martinez-Aguayo, Alejandro
    Campino, Carmen
    Carvajal, Cristian
    Fardella, Carlos
    Garcia, Hernan
    NUTRICION HOSPITALARIA, 2014, 29 (02) : 350 - 358
  • [2] Glycogenic hepatopathy associated with hepatic steatosis in type 1 diabetes
    Teasdale, Stephanie
    Dong, Xin
    Griffin, Alison
    Clark, Paul James
    Nisbet, Janelle
    Morton, Adam
    Phillips, Liza
    Sullivan, Mitchell Anthony
    Galloway, Graham
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (11)
  • [3] Insulin resistance and hepatic steatosis in type 1 diabetes mellitus and their association with diabetic chronic complications
    Popa, Simona G.
    Simion, Ana M.
    Soare, Mariana
    Arcomita, Doina
    MINERVA ENDOCRINOLOGY, 2023, 48 (01): : 27 - 34
  • [4] The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes
    Hashimoto, Yoshitaka
    Osaka, Takafumi
    Fukuda, Takuya
    Tanaka, Muhei
    Yamazaki, Masahiro
    Fukui, Michiaki
    ENDOCRINE JOURNAL, 2016, 63 (10) : 877 - 884
  • [5] Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes
    Fennoun, Halima
    El Mansouri, Souhaila
    Tahiri, Mohammed
    Haraj, Nassim Essabah
    El Aziz, Siham
    Hadad, Fouad
    Hliwa, Wafaa
    Badr, Wafaa
    Chadli, Asma
    PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 270
  • [6] Association of Diabetic Retinopathy with Midlife Hepatic Steatosis Diagnosed by Elastography and Hepatic Steatosis Index in Type 2 Diabetes in an Indian Population
    Mandal, Mily
    Ghosh, Sambuddha
    Roy, Satarupa
    Mandal, Sayani
    Dasgupta, Anindya
    METABOLIC SYNDROME AND RELATED DISORDERS, 2024, 22 (03) : 214 - 221
  • [7] High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus
    Gupta, Aanchal
    Anoop, Shajith
    Ansari, Irshad Ahmad
    Prakash, Satya
    Misra, Anoop
    CLINICAL NUTRITION ESPEN, 2021, 46 : 519 - 526
  • [8] Factors associated with hepatic steatosis in adult Greek subjects with type 2 diabetes mellitus
    Meritsi, Angeliki
    Manesis, Emanuel
    Noutsou, Marina
    Koussis, Panagiotis
    Rapti, Stamatia
    Latsou, Dimitra
    Tsorlalis, Ioannis
    Tsitsopoulos, Eustathios
    Moshoyianni, Hariklia
    Manolakopoulos, Spilios
    Pektasides, Dimitrios
    Thanopoulou, Anastasia
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S2 - S3
  • [9] Hepatic steatosis and type 2 diabetes mellitus.
    Clark J.M.
    Diehl A.M.
    Current Diabetes Reports, 2002, 2 (3) : 210 - 215
  • [10] Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
    Mantovani, Alessandro
    Morieri, Mario Luca
    Palmisano, Luisa
    Masulli, Maria
    Cossu, Efisio
    Baroni, Marco Giorgio
    Bonomo, Katia
    Cimini, Flavia Agata
    Cavallo, Gisella
    Buzzetti, Raffaella
    Mignogna, Carmen
    Leonetti, Frida
    Bacci, Simonetta
    Trevisan, Roberto
    Pollis, Riccardo Maria
    Aldigeri, Raffaella
    Cas, Alessandra Dei
    de Kreutzenberg, Saula Vigili
    Targher, Giovanni
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)